These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36321825)

  • 1. Probiotic Bifidobacteria Mitigate the Deleterious Effects of
    Stuivenberg GA; Chmiel JA; Akouris PP; Burton JP; Reid G
    mSphere; 2022 Dec; 7(6):e0044622. PubMed ID: 36321825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate.
    Młynarska E; Budny E; Saar M; Wojtanowska E; Jankowska J; Marciszuk S; Mazur M; Rysz J; Franczyk B
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
    Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease.
    Dong Y; Gai Z; Han M; Xu J; Zou K
    Probiotics Antimicrob Proteins; 2024 Jun; ():. PubMed ID: 38829564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure.
    Di Paola R; De A; Izhar R; Abate M; Zappavigna S; Capasso A; Perna AF; La Russa A; Capasso G; Caraglia M; Simeoni M
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    McFarlane C; Ramos CI; Johnson DW; Campbell KL
    J Ren Nutr; 2019 May; 29(3):209-220. PubMed ID: 30366767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.
    Barba C; Soulage CO; Caggiano G; Glorieux G; Fouque D; Koppe L
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary strategies for gut-derived protein-bound uremic toxins and cardio-metabolic risk factors in chronic kidney disease: A focus on dietary fibers.
    Melekoglu E; Samur FG
    Crit Rev Food Sci Nutr; 2023; 63(19):3994-4008. PubMed ID: 34704501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients-A Randomized Trial.
    Mitrović M; Stanković-Popović V; Tolinački M; Golić N; Soković Bajić S; Veljović K; Nastasijević B; Soldatović I; Svorcan P; Dimković N
    J Ren Nutr; 2023 Mar; 33(2):278-288. PubMed ID: 35995418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota issue in CKD: how promising are gut-targeted approaches?
    Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
    J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota-Mediated Modulation of Organophosphate Insecticide Toxicity by Species-Dependent Interactions with Lactobacilli in a Drosophila melanogaster Insect Model.
    Daisley BA; Trinder M; McDowell TW; Collins SL; Sumarah MW; Reid G
    Appl Environ Microbiol; 2018 May; 84(9):. PubMed ID: 29475860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Synbiotic Supplementation on Uremic Toxins, Oxidative Stress, and Inflammation in Hemodialysis Patients-Results of an Uncontrolled Prospective Single-Arm Study.
    Kuskunov T; Tilkiyan E; Doykov D; Boyanov K; Bivolarska A; Hristov B
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629672
    [No Abstract]   [Full Text] [Related]  

  • 16. The Potential Benefits and Controversies of Probiotics Use in Patients at Different Stages of Chronic Kidney Disease.
    Tian N; Li L; Ng JK; Li PK
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut microbiome, kidney disease, and targeted interventions.
    Ramezani A; Raj DS
    J Am Soc Nephrol; 2014 Apr; 25(4):657-70. PubMed ID: 24231662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiota and its relationship with chronic kidney disease.
    Plata C; Cruz C; Cervantes LG; Ramírez V
    Int Urol Nephrol; 2019 Dec; 51(12):2209-2226. PubMed ID: 31576489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS.
    Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P
    Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel intestinal dialysis interventions and microbiome modulation to control uremia.
    Sumida K; Lau WL; Kalantar-Zadeh K; Kovesdy CP
    Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):82-91. PubMed ID: 34846313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.